Oppenheimer Initiates Coverage On Viatris with Outperform Rating, Announces Price Target of $25

9/23/2026
Impact: 70
Healthcare

Oppenheimer analyst Les Sulewski has initiated coverage on Viatris (NASDAQ: VTRS) with an Outperform rating. The firm has set a price target of $25 for the company's stock.

AI summary, not financial advice

Share: